Genentech is dismantling its cancer immunology team in a reorganization of its work in the field, and its VP of cancer immunology, Ira Mellman, will …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Acadia Pharmaceuticals is acquiring further rights to Neuren Pharmaceuticals’ newly approved Rett syndrome treatment for $100 million amid a better-than-expected launch of the drug. The
Government regulation was effective for increasing bystander CPR and public automated external defibrillator (AED) use even in a limited-resource setting, according to registry data from
WASHINGTON — For an app that helps pharmacies in Africa manage their medicines, the term “pharmacy benefit manager” has become a dirty word. The organization,